$CRBG

Wednesday’s insider buys and sells: Nippon Life leads purchases

Nippon Life bought 162,024 Corebridge Financial (CRBG) shares for $5.59M. ADAR1 Capital acquired 922,849 Tenax Therapeutics (TENX) shares for $1.46M. Orrin H. Ingram II bought 29,081 FB Financial (FBK) shares for $1.54M. Troy A. Ignelzi purchased 5,500 Rapport Therapeutics (RAPP) shares for $143,550. Saba Capital bought $386,338 of ELLSWORTH GROWTH & INCOME FUND (ECF). Frank Slootman sold $94.9M of Snowflake (SNOW). Chevron (CVX) CLO sold $9.77M in shares.

Original reporting
Published Oct 22, 2026, 1:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CRBG
Bullish
medium confidence
Mentioned
$CRBG · $TENX · $FBK · $RAPP · $ECF · $SNOW
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CRBGBullishLow
01

Why it matters

Mixed signals: buys suggest confidence in some stocks, while sizable sells could pressure others.

02

Market read

Provides traders with fresh insider transaction data to gauge short‑term sentiment.

03

What to watch

Some purchases are under 10b5‑1 plans, reducing predictive value.

Relevance 4/10Novelty 3/10Timing: today

Background

Weekly Form 4 roundup of notable insider purchases and sales for U.S. listed companies.

Company-level read

Ticker impact

$CRBGBullishMedium confidence
Context

Nippon Life, a 10% owner, bought 162,024 shares of Corebridge Financial for $5.59M.

Expected impact

potential modest upside as insiders add to position

Evidence & confidence

Large insider purchase under 10b5-1 plan suggests confidence but limited market impact.

$TENXBullishMedium confidence
Context

ADAR1 Capital Management purchased ~922,849 shares of Tenax Therapeutics for $1.46M.

Expected impact

likely short‑term support as insiders accumulate shares

Evidence & confidence

Buy at low valuation may attract other investors.

$FBKBullishLow confidence
Context

Orrin H. Ingram II bought roughly $1.54M of FB Financial shares.

Expected impact

modest upward pressure

Evidence & confidence

Purchase size modest relative to market cap.

$RAPPBullishLow confidence
Context

CFO Troy Ignelzi bought 5,500 shares of Rapport Therapeutics for $143,550.

Expected impact

minor support for stock

Evidence & confidence

Small transaction size.

$ECFBullishLow confidence
Context

Saba Capital Management acquired $386,338 of ECF shares.

Expected impact

limited impact

Evidence & confidence

Fund size and transaction modest.

$SNOWBearishMedium confidence
Context

Frank Slootman sold about $94.9M of Snowflake shares.

Expected impact

potential downside as market absorbs sell

Evidence & confidence

Significant dollar amount from CEO.

$CVXBearishLow confidence
Context

Chevron legal officer sold roughly $9.77M of CVX shares.

Expected impact

slight pressure, but high valuation may offset

Evidence & confidence

Sell size moderate relative to market cap.

$GRNDBearishMedium confidence
Context

Director George Zage III sold 500,000 Grindr shares for $7.06M.

Expected impact

downward pressure

Evidence & confidence

Half‑million share sale at low price.

Market effects

Insider activity across financials, energy, biotech may hint at sector confidence levels.

U.S. equity market, no broader regional effect.

Limited to listed U.S. companies.

Counterpoint

Large insider sells may be routine liquidity events, not bearish signals.

Key entities

  • Corebridge Financial

    Insurance holding company.

  • Snowflake

    Cloud data warehousing firm.

Related articles

$CVXMed

Chevron uses Permian playbook to breathe life into Argentina's 'Dead Cow' oil region

Chevron is investing in Argentina's Vaca Muerta shale basin, aiming to triple production by 2035. The company plans to spend $13.8 billion over 30 years, adding two more drilling rigs by 2029. Despite higher costs, Chevron sees potential in the region, which is benefiting from recent government reforms. Chevron's projects in Vaca Muerta include El Trapial, Loma Campana, and Narambuena.

$CVXMed

Chevron Eyes $1B Gulf Asset Sale to Focus on Growth Projects

Chevron (CVX) is exploring a $1B sale of U.S. Gulf assets, including Petronius, Tubular Bells, and Llano, to focus on growth projects like Anchor and Ballymore. The sale aims to reach 300,000 barrels of oil equivalent per day by 2026. Potential buyers may include global and domestic energy companies, according to sources.

$CVXMed

Chevron Stock Hits New 52-Week High - Here's Why

Chevron (CVX) shares reached a new 52-week high, trading at $229.30 premarket. Brent crude rose 3% to $112 due to Middle East tensions. Chevron may sell U.S. Gulf assets for around $1 billion. Q3 2026 EPS and revenue estimates are $4.88 and $61.11 billion, respectively. Analysts maintain a Buy rating with an average target of $226.77.

$CVXMed

Chevron Explores Sale Of Older U.S. Gulf Oil And Gas Assets To Focus On Growth

Chevron (CVX) is considering selling older U.S. Gulf oil and gas assets, including Petronius, Tubular Bells, and Llano, to focus on growth projects. The company aims to reach 300,000 barrels of oil equivalent per day in U.S. Gulf production by year-end. Sales could bring in about $1 billion, with interested buyers including international and U.S. energy companies. Chevron's stock has risen 22% in the last 6 months, with a current price of $227 and a target of $231.